In the beginning, it was just the proteins.
The way biochemist Christian Schwabe saw it, Darwinian evolution should have given closely related animals similar sets of proteins.
It was a simple idea, just a way to prove the cellular legacy of millions of years of common ancestry. Only it didn’t work.
The mismatched proteins were just a stray thread in the grand tapestry of life, yet the flaw gnawed at the back of the professor’s mind – until one day at Harvard University in 1970, when a new idea struck him in the middle of a lecture.
"That’s not going to work that way," Dr. Schwabe said aloud, and his students watched in bewilderment as their instructor spent the rest of the class working out the first bits of his idea on the blackboard.
What Dr. Schwabe began that day would become, by 1984, something he called the "genomic potential hypothesis:" the idea that life on Earth arose not from a single, random-chance event, but from multiple, predictable, chemical processes.
As bold as that idea seemed, it was tame compared with the second part of his theory: that evolution by natural selection – a cornerstone of Darwinian thought – was a 19th-century illusion.
Rather than a world of diversely adapted species with one common origin, Dr. Schwabe saw each modern species as the ultimate expression of its own independent origin.
Evolution wasn’t about adaptation, Dr. Schwabe said, but the perfection of each species’ original "genomic potential."
He and a colleague published the first paper on the idea in 1984, and the German-born professor settled in to await the inevitable critical response. It never came.
More articles in small academic journals followed in 1985 and 1990, but they, too, failed to provoke debate.
Today, Dr. Schwabe is a professor of biochemistry at the Medical University of South Carolina, a federally funded investigator who has accounted for more than $4 million in research funding, much of it related to drugs that regulate blood flow.
He has published more than 100 scholarly works and received five patents for his discoveries.
Yet when it comes to his most provocative idea, Dr. Schwabe is practically an invisible man. His articles on genomic potential hypothesis – GPH – typically are returned without meaningful comment by editors, most recently by the prestigious journal Science, and sometimes it seems as if the only people paying attention to his work are Internet fringe-dwellers.
"I think one of the most brilliant and bravest thinkers in America lives in Charleston, S.C.," said Ron Landes, a scientific publisher from Texas, "and nobody knows about him."
All he wants, Dr. Schwabe says, is a hearing by his peers.
"If they don’t like it, they should tell me factually what is wrong," he said. "If they think it’s no good, they have the obligation to disprove it."
That’s the ideal of science we all learned in grade school. But as Dr. Schwabe continues to demonstrate, the practice of science is a bit more complex.
It takes an educated specialist to evaluate scientific claims; new discoveries are practically meaningless until they are published in major journals.
Publication signifies that the science behind an article is solid and that the idea, right or wrong, is worthy of study. This system of establishing credibility, called peer review, is essential to the scientific process, yet not every idea is worthy of serious, high-level peer review.
But the critical question in Dr. Schwabe’s case isn’t whether peer review works – rather, it’s, "Can unorthodox but potentially significant ideas get access to legitimate peer review?"
Though peer review remains essential to the scientific method, "It is not a requirement that anyone else pay attention to you," said Jerry Hilbish, professor of biological sciences at the University of South Carolina.
Yet the big journals also have a lot to lose by missing out on a big breakthrough, he said.
"It is normal in science for new ideas that contradict old ones to be resisted or ignored for a while," Dr. Bauer said. "Many people in that situation are stunned that they’re not being listened to, because science is supposed to be so open to new ideas. But the reality is that (science) is open to new things, but just not things that are too new."
File Date: 4.17.04
This data file may be reproduced in its entirety
for non-commercial use.
A return link to the Access Research Network web site would be
appreciated.
Documents on this site which have been reproduced from a previous publication are copyrighted through the individual publication. See the body of the above document for specific copyright information.